
Right on the heels of our press release announcing a deal with Novo Nordisk, we're thrilled to see this NY Times coverage of the partnership and Variant Bio's ethics-first approach to drug discovery: nytimes.com/2025/01/07/healt…
✓People-Driven Therapeutics

Right on the heels of our press release announcing a deal with Novo Nordisk, we're thrilled to see this NY Times coverage of the partnership and Variant Bio's ethics-first approach to drug discovery: nytimes.com/2025/01/07/healt…

An incredible story by @bborrell and work from @VariantBio. It’s a reminder that science is a long game—and that technology companies can be both world-changing and community-focused. Also, great science journalism is a public good worth supporting. Props to @ashleevance and team.

New coverage in @corememory tells the origins of @VariantBio’s first drug candidate, and the power of human genetics to discover new medicines: medium.com/variantbio/from-t…

Excellent by @ashleevance + @bborrell on Lux family co @VariantBio

New piece out about @VariantBio's lead drug program in pulmonary fibrosis and Dr. Alain Dessein, our inspiring research collaborator in Uganda:

Announcing our newest paper on the genetics of kidney disease co-authored with research partners from South Africa and Uganda: medium.com/variantbio/new-pu…

Thanks to Dr. @hibababiker2 for representing @VariantBio and sharing our approach to benefit sharing at #ASHG26 in Montreal last week!

Findings from our recent papers in @ScienceMagazine and @NatureComms include health risks and drug-target leads the largest databases miss: medium.com/variantbio/two-pa…

With co-author @stephanecastel of @VariantBio in front of our cover of @ScienceMagazine at ASHG @GeneticsSociety in Montreal. Come to their booth and get a free copy! Missing my co-senior author @KeoluFox.

Lux family co @VariantBio we created + funded this company to find outlier people in outlier parts of the world with outlier traits... to develop new drugs for all of the rest of us.

Out today on the cover of @ScienceMagazine: work led by @KeoluFox (UCSD) and Alexander Ioannidis (Stanford) with @VariantBio. Polynesians experienced founder effects 10x stronger than Finland’s, with big implications for drug discovery and clinical care: science.org/doi/10.1126/scie…

Dr. Sarah LeBaron von Baeyer from Variant Bio presenting with our brilliant partner Dr. June Fabian from the University of the Witwatersrand on how we have together implemented the community-driven distribution of financial benefits for genomics research projects in South Africa.

Variant Bio leverages AI-powered Inference platform in an expanded collaboration with @Boehringer: medium.com/variantbio/expand…

Thrilled to announce our latest drug development collaboration! We are now expanding our existing partnership with @Boehringer into cardiovascular disease for a total potential deal value exceeding $250 mm: prnewswire.com/news-releases…

Check out this upcoming webinar by our very own @OliviaG_PhD! Register here 👉 zoom.us/webinar/register/WN_…

Variant Bio’s Senior Director of Ethics & Engagement discusses lessons learned from educational and health initiatives in Rwanda: medium.com/variantbio/taking…